Qin Chen

Mrs. Qin Chen

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
GHGenping Huang
Genping Huang
RCRuizhe Chen
Ruizhe Chen
NLNanjia Lu
Nanjia Lu
QCQin Chen
Qin Chen
WLWeiguo Lu
Weiguo Lu
BLBaohua Li
Baohua Li
Purpose: There is currently a lack of research on preoperative prognostic analysis of early-stage cervical adenocarcinoma (ADC). The purpose of our study was to clarify whether preoperative serum tumor-marker levels were of prognostic value in early-stage ADC. Patients and Methods: We performed a retrospective study of patients with International Federation of Gynecology and Obstetrics (FIGO) stage IA1–IIA1 and pathology-proven invasive ADC. We evaluated the relationship between preoperative serum tumor-marker levels and clinicopathological characteristics, and identified the relative preoperative risk factors affecting disease-free survival (DFS) and overall survival (OS). The optimal cut-off point of meaningful tumor markers was determined by the analysis of receiver operating characteristics (ROC), and the accuracy of the results was evaluated by the area under the curve (AUC). Results: Elevated carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125), squamous cell carcinoma antigen (SCC-Ag), alpha-fetoprotein (AFP), carbohydrate antigen 153 (CA153) and carbohydrate antigen 199 (CA199) were associated with certain clinicopathologic features of early-stage ADC. The combination of elevated serum CEA and CA125 was significantly associated with FIGO stage, body mass index (BMI) and LNM. Kaplan–Meier survival curve and Cox regression analyses revealed that CEA and CA125 might have significant prognostic implications in early-stage ADC patients, and the combination of elevated serum CEA and CA125 served as an independent predictor of early-stage ADC. The optimal cut-off point of serum CA125 for prediction DFS and OS was 32.60 U/mL and of serum CEA were 2.85 ng/mL and 2.05 ng/mL, respectively. The AUC showed that serum CEA was a moderate predictor of OS. Conclusion: The preoperative serum levels of CEA and CA125 might have significant prognostic implications in early-stage ADC patients. Combined preoperative serum CEA and CA125 levels independently predicted the prognosis of early-stage ADC.

8 December 2017 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
QCQin Chen
Qin Chen
GCGuiying Chen
Guiying Chen
NLNan Li
Nan Li

1 June 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
XTXiaoyu Tu
Xiaoyu Tu
RCRuizhe Chen
Ruizhe Chen
GHGenping Huang
Genping Huang
NLNanjia Lu
Nanjia Lu
QCQin Chen
Qin Chen
BLBaohua Li
Baohua Li
Purpose: To investigate the potential factors to predict severe myelosuppression among low-risk gestational trophoblastic neoplasia (GTN) patients with single-agent methotrexate (MTX) chemotherapy. To analyze reproductive outcomes of patients with or without severe myelosuppression after achieving complete remission (CR). Patients and Methods: The retrospective study included 319 low-risk GTN patients registered from January 2008 to December 2018 in our hospital. Patients were divided into two groups according to myelosuppression grading. Their clinical data and reproductive outcomes were compared and analyzed. Results: A higher proportion of patients in group A received second-line chemotherapy than group B (P< 0.001). The number of total chemotherapy courses was more in group A than group B (P=0.001), while the number of MTX chemotherapy courses was more in group B than group A (P=0.001). When the joint predictor of pretreatment albumin (ALB) was not more than 44.5 g/L, pretreatment serum creatinine (Scr) was not less than 75.6 μmol/L, and the number of MTX chemotherapy courses was not less than four, there was a moderate predictive value. There was no significant difference of reproductive outcomes between the two groups after achieving CR. Conclusion: Although some patients developed severe myelosuppression, MTX was still the effective first-line treatment for low-risk GTN patients. Patient’s pretreatment ALB was not more than 44.5 g/L, pretreatment Scr was not less than 75.6 μmol/L, and the number of MTX chemotherapy courses not less than four could be used as combined predictors to recognize the risk of severe myelosuppression. Severe myelosuppression had no significant adverse influence on fertility after achieving CR.

1 January 2024 in Journal of Food Biochemistry
Verified
Journal Article
Open access
WWWenwen Wang
Wenwen Wang
MBMuhammad Qasim Barkat
Muhammad Qasim Barkat
SASehrish Amin
Sehrish Amin
AAAbdulrahman Alshammari
Abdulrahman Alshammari
NANoorah A. Albekairi
Noorah A. Albekairi
QCQin Chen
Qin Chen
A multidisciplinary endocrinopathy affecting women in their reproductive years, polycystic ovarian syndrome, causes insulin resistance, hyperandrogenism, cardiovascular issues, obesity, and menstrual difficulties. Cuminum cyminum (cumin seed) is a famous spice traditionally used for various ailments such as indigestion, headache, diarrhea, obesity, and gynecological disorders. This study explored the pharmacological potential of aqueous ethanolic extract of Cuminum cyminum (AECC) in letrozole‐induced PCOS animals, which were also obese. HPLC analysis revealed the presence of chlorogenic acid, gallic acid, hydroxybenzoic acid (HB acid), caffeic acid, vanillic acid, kaempferol, sinapic acid, ferulic acid, salicylic acid, coumarin, quercetin, benzoic acid, rutin, and p‐coumaric acid. Thirty adult female rats were divided into six groups (5 animals in each group). PCOS was induced by using letrozole (1 mg/kg). The groups were normal control, diseased control, standard (metformin, 20 mg/kg), and AECC (200, 400, and 600 mg/kg). Vaginal smear cytology was used to confirm the PCOS. The animals were euthanized after 12 weeks, and blood was drawn for hormonal and biochemical study. We used isoflurane 5% for euthanasia in a closed chamber. The ovaries were removed for histopathology. Ovarian histopathology showed abnormalities with cystic follicles in PCOS female rats. It also produced hyperinsulinemia, LH surge, lower FSH, perturbed LH/FSH ratio, and higher levels of testosterone and weight gain. Moreover, it also produced oxidative stress with ROS (reactive oxygen species) production. Meanwhile, AECC treatment converted cystic follicles into primary, secondary, and differentiating follicles with healthy granulosa cells and corpus luteum with significant (p < 0.001) weight loss. AECC significantly (p < 0.001) reduced serum insulin levels and normalized LH/FSH ratio, with improved FSH levels and control of LH surge. AECC also reduced oxidative stress and lipid peroxidation with significant (p < 0.001) improvement of antioxidant markers. It has been concluded that AEEC can alleviate PCOS symptoms by improving insulin resistance, reducing weight, addressing hyperandrogenism, regulating the LH/FSH ratio, and overcoming oxidative stress and ROS production.

21 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
QCQin Chen
Qin Chen
BYBo Yang
Bo Yang
Norbert NassNorbert Nass
Norbert Nass
CSChristoph Schatz
Christoph Schatz
JHJohannes Haybäck
Johannes Haybäck
Breast carcinoma (BC) remains one of the most serious health problems. It is a heterogeneous entity, and mainly classified according to receptor status for estrogen (ER), progesterone (PR) and egf (HER2/Neu), as well as the proliferation marker ki67. Gene expression in eukaryotes is regulated at the level of both gene transcription and translation, where eukaryotic initiation factors (eIFs) are key regulators of protein biosynthesis. Aberrant translation results in an altered cellular proteome, and this clearly effects cell growth supporting tumorigenesis. The relationship between various eIFs and BC entities, as well as the related regulatory mechanisms, has meanwhile become a focus of scientific interest. Here, we give an overview on the current research state of eIF function, focusing on BC.

22 July 2022 in Medicine
Verified
Journal Article
Open access
JZJiashan Zou
Jiashan Zou
WDWeimin Ding
Weimin Ding
QCQin Chen
Qin Chen
XBXiaoxia Bai
Xiaoxia Bai
BLBaohua Li
Baohua Li
This study aimed to examine the maternal and neonatal outcomes in different mode of delivery in pregnant women with placental chorioangiomas, in order to determine the safety of vaginal delivery. We conducted a retrospective study of 54 women with placental chorioangioma diagnosed by prenatal ultrasound and subsequently proven histologically, excluding those who underwent cesarean section for obstetric indications. The mode of delivery was divided into a vaginal delivery group (23 women) and a cesarean section group (31 women). The indication of cesarean section group was only for placental chorioangioma, no other obstetric indications. The maternal characteristics, pregnancy outcomes and the color doppler imaging characteristics of placental chorioangioma of the 2 groups were compared, and the clinical characteristics of women in the vaginal delivery group were described in detail. The incidence of placental chorioangioma was nearly 0.43‰ in our study. There was no significant difference in the maternal characteristics and pregnancy outcomes between the 2 groups. 82.6% (19/23) of the women successfully delivered vaginally and 4 failed who turned to cesarean section in the vaginal delivery group; among them, 17 women had giant chorioangiomas (>4 cm in diameter). The direct cause of vaginal delivery failure was fetal distress, persistent occiput posterior fetal position and cephalopelvic disproportion. Pregnant women with placental chorioangiomas and no other obstetric indications for cesarean section may attempt a vaginal delivery, even with giant chorioangiomas. If there are risk factors of vaginal delivery failure, the progress of labor needs to be closely monitored.